ADIM
SWAV

Alpha DNA Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Alpha DNA Investment Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11
Closed -$1K – 700
2021
Q1 		$1K Sell
11
-3
-21% -$360 ﹤0.01% 667
2020
Q4 		$1K Buy
+14
New +$1.21K ﹤0.01% 566

Other funds holding SWAV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Alpha DNA Investment Management's SWAV Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2021, closing a stake of 11 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in SWAV in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 240 funds tracked by Wall St. Rank hold SWAV as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 11 Shockwave Medical, Inc. Common Stock shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $1K in Q1 2021.
  • 240 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.